DePuy Mitek RF electrode launch
This article was originally published in The Gray Sheet
J&J division launches VAPR Premiere90 low-profile, small-diameter radiofrequency electrode, which is 510(k)-cleared for use on the VAPR electrosurgical system for soft tissue ablation and coagulation during arthroscopic procedures. The device features a 3.3 mm tip and 3.7 mm shaft that allows for easy insertion, maneuverability and access to small or constricted areas, Depuy Mitek says in an Oct. 13 release. In addition, it can ablate hard tissue 20% faster than comparable devices at its default power setting, and its energy settings can be independently adjusted to optimize power for faster or controlled coagulation, according to the firm. The electrode also includes central and peripheral suction ports to improve visualization by quickly removing bubbles and small debris
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”